Conclusion: Strict glycemic control, in addition to neuroprotective measures in this pre-retinopathy phase may offer a promising treatment choice by decelerating the progression to overt retinopathy.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: A considerable amount of evidence is pointing out the possible contribution of neurodegeneration in the etiopathogenesis of diabetic retinopathy (DR).
📊
Key Findings & Data:Materials and Methods: The evaluation and correlation of the neurodegenerative findings in the inner retinal layers with the choroid of patients with type 2 diabetes mellitus (DM) without DR via optic coherence tomography (OCT) are aimed in this study.
💡
Conclusion & Impact:Conclusion: Strict glycemic control, in addition to neuroprotective measures in this pre-retinopathy phase may offer a promising treatment choice by decelerating the progression to overt retinopathy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: A considerable amount of evidence is pointing out the possible contribution of neurodegeneration in the etiopathogenesis of diabetic retinopathy (DR). Materials and Methods: The evaluation and correlation of the neurodegenerative findings in the inner retinal layers with the choroid of patients with type 2 diabetes mellitus (DM) without DR via optic coherence tomography (OCT) are aimed in this study. Results: Neuronal and axonal loss seems to occur early in DM before the ophthalmoscopic vascular changes. Conclusion: Strict glycemic control, in addition to neuroprotective measures in this pre-retinopathy phase may offer a promising treatment choice by decelerating the progression to overt retinopathy.
🔖
Cite This Article
KARAKAHYA, R. H. (2022). Choroid and Retina: A potential guide for glycemic controlof diabetes mellitus without diabetic retinopathy. Annals of Medical Research, Cilt: 28 - Sayı: 7, 1308–1314. https://ajindex.com/articles/445804
Yau JW, Rogers SL, Kawasaki R, et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64
Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-91
Barber AJ. A new view of diabetic retinopathy: A neurodegenerative disease of the eye. Prog. Neuropsychopharmacol Biol Psychiatry 2003;27:283- 90
Han Y, Adams AJ, Bearse MA, Jr, et al. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol 2004;122:1809-15
Balta O, Sungur G, Yakin M, et al. Pattern visual evoked potential changes in diabetic patients without retinopathy. J Ophthalmol 2017;2017:8597629
Drasdo N, Chiti Z, Owens DR, et al. Effect of darkness on inner retinal hypoxia in diabetes. Lancet 2002;359:2251-3
Sokol S, Moskowitz A, Skarf B, et al. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 1985;103:51-4
Roy MS, Gunkel RD, Podgor MJ. Color Vision Defects in Early Diabetic Retinopathy. Arch Ophthalmol. 1986;104:225-8
Barber AJ, Baccouche B. Neurodegeneration in diabetic retinopathy: Potential for novel therapies. Vision Res 2017;139:82-92
Massin P, Vicaut E, Haouchine B, et al. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001;119:1135-42. 11. van Dijk HW, Verbraak FD, Kok PH, et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci 2012;53:2715-9. 12. van Dijk HW, Verbraak FD, Kok PHB, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010;513660-5
Pierro L, Iuliano L, Cicinelli MV, et al. Retinal neurovascular changes appear earlier in type 2 diabetic patients. Eur J Ophthalmol 2017;27:346-51
Ferreira JT, Vicente A, Proença R, et al. Choroidal thickness in diabetic patients without diabetic retinopathy. Retina 2018;38:795-804
Kadlubowska J, Malaguarnera L, Waz P, et al. Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss. Curr Neuropharmacol 2016;14:831-9
Chhablani J, Sharma A, Goud A, et al. Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography. Invest Ophthalm